Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection.

Autor: Lanfermeijer J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Nühn MM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands., Emmelot ME; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands., Poelen MCM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands., van Els CACM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CX Utrecht, The Netherlands., Borghans JAM; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., van Baarle D; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Kaaijk P; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands., de Wit J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.
Jazyk: angličtina
Zdroj: Vaccines [Vaccines (Basel)] 2021 Dec 03; Vol. 9 (12). Date of Electronic Publication: 2021 Dec 03.
DOI: 10.3390/vaccines9121431
Abstrakt: Waning of the mumps virus (MuV)-specific humoral response after vaccination has been suggested as a cause for recent mumps outbreaks in vaccinated young adults, although it cannot explain all cases. Moreover, CD8 + T cells may play an important role in the response against MuV; however, little is known about the characteristics and dynamics of the MuV-specific CD8 + T-cell response after MuV infection. Here, we had the opportunity to follow the CD8 + T-cell response to three recently identified HLA-A2*02:01-restricted MuV-specific epitopes from 1.5 to 36 months post-MuV infection in five previously vaccinated and three unvaccinated individuals. The infection-induced CD8 + T-cell response was dominated by T cells specific for the ALDQTDIRV and LLDSSTTRV epitopes, while the response to the GLMEGQIVSV epitope was subdominant. MuV-specific CD8 + T-cell frequencies in the blood declined between 1.5 and 9 months after infection. This decline was not explained by changes in the expression of inhibitory receptors or homing markers. Despite the ongoing changes in the frequencies and phenotype of MuV-specific CD8 + T cells, TCRβ analyses revealed a stable MuV-specific T-cell repertoire over time. These insights in the maintenance of the cellular response against mumps may provide hallmarks for optimizing vaccination strategies towards a long-term cellular memory response.
Databáze: MEDLINE